Клинико-патогенетическое значение молекул межклеточной адгезии при хронических заболевания печени
Диссертация
Впервые определены особенности влияния противовирусной терапии на нарушения молекул адгезии при хронических вирусных заболеваниях печени, выявлен более выраженный нормализующий эффект противовирусных средств у больных хроническим вирусным гепатитом С и С-вирусным циррозом печени, достигших устойчивого вирусологического ответа. Впервые оценена роль исходных значений показателей 1САМ-1 и УСАМ-1 как… Читать ещё >
Список литературы
- Абдурахманов, Д. Т. Пегилированный интерферон-а в лечении хронического гепатита В / Д. Т. Абдурахманов, С. В. Моисеев // Клин, гепатол. — 2007. — № 1. — С. 25−29.
- Абдурахманов, Д. Т. Противовирусная терапия хронического гепатита С: пришло ли время менять стандарты? / Д. Т. Абдурахманов // Росс, журн. гастроэнтерол., гепатол., колопроктол. 2009. — № 1. — С. 16−21.
- Гейвандова, Н. И. Медиаторы воспаления в патогенезе, диагностике и лечении хронических вирусных заболеваний печени: Автореф. дис. д-ра мед. наук / Н. И. Гейвандова. Ставрополь: Изд-во СтГМА, 2001. -34 с.
- Гиясов, М. М. Значение оксида азота в прогрессировании портальной гипертензии / М. М. Гиясов, С. А. Авезов // Росс. журн. гастроэнтерол., гепатол., колопроктол. Материалы 14-й Росс, гастроэнтерол. нед. -2008.-№ 5.-С. 83.
- Диагностика, ведение и лечение НСУ-инфекции. Часть 1 // Росс. журн. гастроэнтерол., гепатол., колопроктол. 2010. — № 1. — С. 61−68.
- Диагностика, ведение и лечение НСУ-инфекции. Часть 2 // Росс. журн. гастроэнтерол., гепатол., колопроктол. 2010. — № 2. — С. 66−72.
- Ивашкин, В. Т. Современные принципы ведения пациентов с хронической инфекцией вирусом гепатита В: клиническое значение уровня вирусной нагрузки / В. Т. Ивашкин, М. В. Маевская // Клин, перепек, гастроэнтерол., гепатол. 2006. — № 5. — С. 1−8.
- Ивашкин, В. Т. Современные схемы лечения больных хроническим вирусным гепатитом С / В. Т. Ивашкин, М. В. Маевская, М. А. Морозова, Е. О. Люсина // Росс. журн. гастроэнтерол., гепатол., колопроктол. 2012. — № 1. — С. 36−44.
- Кароли, Н. А. Эндотелиальная дисфункция и ее клиническое значение у больных хронической обструктивной болезнью легких / Н. А. Кароли, А. П. Ребров // Клин, медицина. 2005. — № 9. — С. 10−16.
- Корой, П. В. Влияние противовирусной терапии на функциональные показатели эндотелия при НСУ-ассоциированной патологии печени / П. В. Корой, А. В. Ягода // Мед. вест. Северного Кавказа. 2009. — № 2. -С. 43−48.
- Корой, П. В. Влияние противовирусной терапии на показатели фибринолиза при хронической вирусной патологии печени / П. В. Корой, А. В. Ягода // Мед. вест. Северного Кавказа. 2010. — № 1. — С. 45−50.
- Корой, П. В. Клинико-патогенетическое и прогностическое значений нарушений гемостатического гомеостаза при хронических заболеваниях печени: Автореф. дис. д-ра мед. наук / П. В. Корой. -Ставрополь: Изд-во СтГМА, 2010. 41 с.
- Корой, П. В. Состояние микроциркуляторного русла у больных хроническим гепатитом С и циррозом печени в динамике, противовирусного лечения / П. В. Корой, В. Б. Зафирова, А. В. Ягода //
- Известия высших учебных заведений. Проблемы гастроэнтерологии Юга России. 2007. — С. 125−127.
- Маевская, М. В. Энтекавир новое в лечении больных хроническимгепатитом В / М. В. Маевская, А. О. Буеверов // Клин, перспект. гастроэнтерол., гепатол. 2007. — № 2. — С. 1−6.
- Никитин, И. Г. Клиника, диагностика и этиопатогенетическое лечение хронического НСУ-гепатита: Автореф. дис. д-ра мед. наук / И. Г. Никитин. М., 2000. — 48 с.
- Никитин, И. Г. Рекомендации по диагностике и подходам к лечению хронического гепатита В / И. Г. Никитин // Клин, перспект. гастроэнтерол., гепатол. 2008. — № 2. — С. 2−15.
- Применение пакета прикладных программ БТАПЕПСА / О. Ю. Реброва. М.: «Медиасфера», 2002. — 312 с.
- Ройт, А. Иммунология / А. Ройт, Дж. Бростофф, Д. Мейл // Пер. с англ. -М.: Мир, 2000.-592 с.
- Структура осложнений и летальность у больных циррозом печении / Г. И. Сторожаков Н. Н. Мерзликина, И. Г. Федоров и др. // Росс. журн. гастроэнтерол., гепатол., колопроктол. Материалы 14-й Росс. конф. «Гепатология сегодня». 2009. — № 1. — С. 19.
- Хаитов, Р. М. Иммунология. Норма и патология. / Р. М. Хаитов, Г. А. Игнатьева, И. Г. Сидорович / Учебник. 3-е изд., перераб. и доп. — М.: ОАО «Издательство «Медицина», 2010.-752с.
- Чепель, Э. Основы клинической иммунологии / Э. Чепель, М. Хейни, С. Мисбах, Н. Сновден / Перевод с англ. 5-е изд. — М.: ГЭОТАР-Медиа, 2008.-416 с.
- Abdallah, N. Evaluation of prognostic value of cell adhesion molecules in chronic hepatitis С therapy / N. Abdallah, M. Morsi, N. Hamed, H. Abdel Aziz // J. Venom. Anim. Toxins. Incl. Trop. Dis. 2010. — Vol. 16, № 3. — P. 442−448.
- Activation of nuclear factor-кВ and its proinflammatory mediator cascade in the infarcted rat heart / L. Lu, S. S. Chen, J. Q. Zhang et al. // Biochem. Biophys. Res. Commun. 2004. — Vol. 321, № 4. — P. 879−885.
- Adhesion molecules and CXC chemokines in endotoxin-induced liver injury / H. Ohira, K. Abe, J. Yokokawa et al. // Fukushima J. Med. Sci. 2003. -Vol. 49, № l.-P. 1−13.
- Adhesion molecules as a prognostic marker of liver cirrhosis / J. A. Giron-Gonzalez, C. Martinez-Sierra, C. Rodriguez-Ramos et al. // Scand. J. Gastroenterol. 2005. — Vol. 40, № 2. — P. 217−224.
- Afdhal, N. H. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood test? / N. H. Afdhal // Hepalogy. 2003. — Vol. 37. -P. 972−974.
- Altered expression of endothelin, vascular endothelial growth factor, and its receptor in hepatic tissue in endotoxemic rat / S. Zaedi, S. Jesmin, N. Yamaguchi et al. // Exp. Biol. Med. 2006. — Vol. 231. — P. 1182−1186.
- An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases / G. Ghany, D. Nelson, D. Strader et al. // Hepatology. — 2011. — Vol. 54, № 4.-P. 1433−1444.
- Bedossa, P. Sampling variability of the liver fibrosis in chronic hepatitis C I P. Bedossa, D. Dargere, V. Paradis // Hepatology. 2003. — Vol. 38. — P.1449−1457.
- C/T polymorphism of the intercellular adhesion molecule-1 gene (exon 6, codon 469). A risk factor for coronary heart disease and myocardial infarction / H. Jiang, R. M. Klein, D. Niederacher et al. // Int. J. Cardiol. -2002.-Vol. 84.-P. 171−177.
- Calvaruso, V. 2011 European association of the study of the liver hepatitis C virus clinical pratice guidelines / V. Calvaruso, A. Craxi // Liver. Inter. -2012.-Vol. 32, Suppl. l.-P. 2−8.
- Carman, C. V. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them / C. V. Carman, T. A. Springer // J. Cell. Biol. 2004. — Vol. 167. — P. 377−388.
- Castera, L. Noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis C / L. Castera, J.-M. Pawlotsky // Med. Gen. Med. 2005. — Vol. 7, № 4.-P. 39−45.
- Chronic anaemia and adhesion molecules in patients with liver cirrhosis. A preliminary report / C. M. Bruno, C. Sciacca, D. Cilio et al. // Minerva. Gastroenterol. Dietol. 2005.-Vol. 51, 2.-P. 187−191.
- Chronic inflammation and protection from acute hepatitis in transgenic mice expressing TNF in endothelial cells / A. Willuweit, G. Sass, A. Schoneberg et al. // J. Immunol. 2001. — Vol. 167. — P. 3944−3952.
- Circulating adhesion molecules in patients with virus-related chronic diseases of the liver / C. M. Bruno, C. Sciacca, D. Cilio et al. // World. J. Gastroenterol. 2005. — Vol. 11, № 29. — P. 4566−4569.
- Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma / M. Soresi, M. Cervello, G. Lipani et al. // Eur. J. Gastroenterol. Hepatol. 1997. — Vol. 9, № 8. — P. 805−809.
- Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion / J. Garcia-Banuelos, F. Siller-Lopez, A. Miranda et al. // Gene Therapy. 2002. -Vol. 9, № 2.-P. 127−134.
- Clinical significance of serum intercellular adhesion molecule-1 detection in patients with hepatocellular carcinoma / M. H. Mei, J. Xu, Q. F. Shi et al. // World. J. Gastroenterol. 2000. — Vol. 6, № 3. — P. 408−410.
- Cytokine stimulated vascular cell adhesion molecule-1 ectodomain release is regulated by TIMP-3 / R. J. R. Singh, J. C. Mason, E. A. Lidington et al. // Cardiovascular. Research. 2005. — Vol. 67, № 1. — P. 39−49.
- De Franchis, R. Natural history of portal hypertension in patients with cirrhosis / R. De Franchis, M. Prigminani // Clin. Liver. Dis. 2001. — Vol. 5.-P. 645−663.
- Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression / T. Nagaoka, Y. Kaburagi, Y. Hamaguchi et al. // Am. J. Pathol. 2000. — Vol. 157. — P. 237−247.
- Dienstag, J. L. Drug therapy hepatitis B virus infection / J.L. Dienstag // N. Engl. J. Med. 2008. — Vol. 359. — P. 1486−1500.
- Distribution of nitric oxide synthase in normal and cirrhotic human liver / L. McNaughton, L. Puttagunta, M. A. Martinez-Guesta et al. // Proc. Natl. Acad. Sci. USA. -2002. Vol. 99, № 26. — P. 17 161−17 166.
- Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes / O. Barreiro, M. Yanez-Mo, J. M. Serrador et al. // J. Cell. Biol. 2002. — Vol. 157. — P. 1233−1245.
- E-Selectin gene polymorphisms in Iranian chronic hepatitis B patients / M. Hajilooi, A.-H. M. Alizadeh, M. Ranjbar et al. // Hep. Mon. 2007. — Vol. 7, № 4.-P. 211−216.
- EASL clinical practice guidelines: management of chronic hepatitis B. European Association for the Study of the Liver // J. Hepatol. 2009. — Vol. 50.-P. 227−242.
- EASL clinical practice guidelines: management of hepatitis C virus infection. European Association for the Study of the Liver // J. Hepatol. -2011.-Vol. 55.-P. 245−264.
- Effects of interferon on hepatic intercellular adhesion molecule-1 expression in patients with chronic hepatitis B / R. D. Zheng, C. R. Xu, M. F. Zhang et al. // Nan. Fang. Yi. Ke. Da. Xue. Xue. Bao. 2008. — Vol. 28, № 5. — P. 878−879.
- Effects of thalidomide on the expression of adhesion molecules in rat liver cirrhosis / P. Lv, S. C. Paul, Y. Xiao et al. // Mediators. Inflamm. 2006. -Vol. 26, № 4.-P. 93 253.
- Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity / T. Lisman, T. Bongers, J. Adelmeijer et al. // Hepatology. 2006. — Vol. 44. — P. 53−61. ' ''
- Endothelial activation and circulating adhesion molecules in alcoholic liveridisease / D. H. Adams, P. Burra, S. G. Hubscher et al. // Hepatology. -1994.-Vol. 19, № 3.-P. 588−594.
- Essential role of the adhesion receptor LFA-1 for T cell-dependent fulminant hepatitis / G. Matsumoto, S. Tsunematsu, K. Tsukinoki et al. // J. Immunol. 2002. — Vol. 169. — P. 7087−7096.
- Expression of adhesion molecules on mature cholangiocytes in canal of Hering and bile ductules in wedge biopsy samples of primary biliary cirrhosis / H. Yokomori, M. Oda, M. Ogi et al. // World. J. Gastroenterol. -2005.-Vol. 11, № 28.-P. 4382−4389.
- Expression of ICAM-1 and Topo II in liver carcinoma and hepatic cirrhosis / M. F. Zhang, J. R. Meng, R. D. Zheng et al. // Chin. J. Clin. Experim. Pathol. 2004. — Vol. 20, № 4. — P. 420−422.
- Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 protein and messenger RNA in primary biliary cirrhosis / H. Yokomori, M. Oda, K. Yoshimura et al. // Int. Med. 2003. — Vol. 42, № 10.-P. 947−954.
- Fattovich, G. Hepatocellular carcinoma in cirrhosis: incidence and risk factors / G. Fattovich, T. Stroffolini, I. Zagni, F. Donato // Gastroenterology. 2004. — Vol. 127, № 5. — S. 35−50.
- Friedmann, S. L. Liver fibrosis- from banch to bedside / S. L. Friedmann // J. Hepatol. 2003. — Vol. 30. — P. 38−53.
- Granot, E. Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients / E. Granot, D. Shouval, Y. Ahur // Mediators. Inflamm. 2001. -Vol. 10.-P. 253−258.
- Gressner, A. M. Modern pathogenesis concepts of liver fibrosis suggest stellate cells and TGF-b as major players and therapeutic targets / A. M. Gressner, R. Weiskirchen // J. Cell. Mol. Med. 2006. — Vol. 10. — P. 76−99.
- Gu, X. Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review / X. Gu, C. Ma, D. Yuan, Y. Song //, Transl. Lung. Cancer. Res. 2012. — Vol. 1. — P. 36−44.
- HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C / R. P. Woitas, U. Petersen, D. Moshage et al. // World. J. Gastroenterol. 2002. — Vol. 8. — P. 562−566.
- Hepatic platelet and leukocyte adherence during endotoxemia / R. S. Croner, E. Hoerer, Y. Kulu et al. // Crit. Care. 2006. — Vol. 10. — P. 10.
- Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients /1. F. De Castro, D. Micheloud, J. Berenguer et al. // AIDS. 2010. — Vol. 24, № 13. — P. 2059−2067.
- Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death / F. Degos, C. Christidis, N. Ganne-Carrie et al. // Gut.-2000.-Vol. 47, № l.-P. 131−136.
- Hezode, C. Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety and management in clinical practice / C. Hezode // Liver. Inter. -2012.-Vol. 32, Suppl. l.-P. 32−38.
- High serum levels of endothelial adhesion molecules E-selectin, ICAM-1 and VCAM in fatty liver patients / T. E. Mosa, A. S. Shehatta, A. A. Khayyal et al. // Asian. J. Biochem. 2011. — Vol. 6. — P. 160−170.
- Ho, J. W. Clinical significance of serum vascular cell adhesion molecule-1 levels in patients with hepatocellular carcinoma / J. W. Ho, R. T. Poon, C. S. Tong, S. T. Fan // World J. Gastroenterol. 2004. — Vol. 10, № 14. — P. 20 142 018.
- Hordjik, P. L. Endothelial signalling events during leukocyte transmigration
- P. L. Hordjik // FEBS J. 2006. — Vol. 273. — P. 4408−4415.i
- Horiike, N. Soluble intercellular adhesion molecule-1 in serum in chronic hepatitis B and C / N. Horiike, M. Onji, I. Kumamoto, T. Masumoto // J. Gastroenterol. 1994. — Vol. 29, № 4. — P. 455−459. •
- Hu, K. Q. Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein / K. Q. Hu, C. H. Yu, J. M. Vierling // Proc. Natl. Acad. Sci. USA. 1992. — Vol. 89. — P. 11 441−11 445.
- Huo, T. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond / T. Huo, S.-D. Lee, H.-C. Lin // Liver. Inter. 2008. — Vol. 28, № 5. — P. 606−613.
- Hyperendothelinemia and ICG clearance in alcoholic and nonalcoholic cirrhosis / S. Maruyama, C. Hirayama, S. Yamamoto et al. // Dig. Dis. Sci. 2002. — Vol. 47, № 4. — P. 773−777.
- Stauber, H. Hofer et al. // Clin. Gastroenterol. Hepatol. 2011. — Vol. 9, № 4.-P. 344−350.
- G. Hubscher, J. Shaw et al. // Hepatology. 1991. — Vol. 14, № 3. — P. 426−431.
- Jensen, D. M. Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes / D. M. Jensen // Gastroenterology. 2002. -Vol. 122.-P. 1620−1630.
- Klintman, D. Leukocyte recruitment in hepatic injury: selectin-mediated leukocyte rolling is a prerequisite for CD18-dependent firm adhesion / D. Klintman, R. Schramm, M. D. Menger, H. Thorlacius / J. Hepatol. 2002. — Vol. 36. — P. 53−59.
- Kumagai, N. Expression of functional ICAM-1 on cultured human keratocytes induced by tumor necrosis factor-a / N. Kumagai, K. Fukuda, Y. Fujitsu, T. Nishida // Japanese J. Ophthalmol. 2003. — Vol. 47, № 2. — P. 134−141.
- L-selectin and intercellular adhesion molecule-1 regulate the development of Concanavalin A-induced liver injury / A. Kawasuji, M. Hasegawa, M. Horikawa et al. // J. Leukoc. Biol. 2006. — Vol. 79, № 4. -P. 696−705.
- Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice / K. Sudo, Y. Yamada, H. Moriwaki et al. // Cytokine. 2005. — Vol. 29, № 5. — P. 236−244.i ' i',
- Lawson, C. ICAM-1 signaling in endothelial cells / C. Lawson, S. Wolf// Pharmacol. Rep. 2009. — Vol. 61. — P. 22−32.
- Lengyel, G. Hepatitis C Virus Infection and Depression / G. Lengyel, Z. Aszalys, Z. Tulassay // Hungarian Med. J. 2007. — Vol. 1, № 1. — P. 5562.
- Ley, K. Selectins in T-cell recruitment to non-lymphoid tissues and sites of inflammation / K. Ley, G.S. Kansas // Nat. Rev. Immunol. 2004. -Vol. 4.-P. 325−335.
- Li, T. Research progress of vasculopathy in portal hypertension / T. Li, Z. Yang // World. J. Gastroenterol. 2005. — Vol. 11, № 39. — P. 60 796 084.
- Liu, Y. Expression of SICAM-1 in serum of hepatitis B patients / Y. Liu, X. Li, H. Shi, J. Lu // J. Dalian. Med. Univer. 2007. — Vol. 4. — P. 2531.
- Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-, year follow-up study of 100 norwegian patients admitted to one unit / H. Bell, J. Jahnsen, E. Kittang et al. // Scand. J. Gastroenterol. 2004. — Vol. 39, № 9.p. 858−863.
- Lymphocyte function antigen-1 mediates leukocyte adhesion and subsequent liver damage in endotoxemic mice / X. Li, D. Klintman, G. Weitz-Schmidt et al. // Br. J. Pharmacol. 2004. — Vol. 141, № 4. p. 709−716.
- Macrophages of patients with X-linked thrombocytopenia display an attenuated Wiskott-Aldrich syndrome phenotype / S. Linder, U. Wintergerst,
- C. Bender-Gotze et al. // Immunol. Cell. Biol. 2003. — Vol. 81. — P. 130 136.
- Madhotra, R. Prediction of esophageal varices in patients with cirrhosis / R. Madhotra, H. E. Mulcahy, I. Willner, A. Reuben // J. Clin. Gastroenterol. 2002. — Vol. 34, № 1. — P. 81−85.
- Maeda, K. Dexamethasone inhibits tumor necrosis factor-a-induced cytokine secretion from spiral ligament fibrocytes / K. Maeda, K. Yoshida, I. Ichimiya, M. Suzuki // Hearing Research. 2005. — Vol. 202, № 1−2. — P. 154−160.
- McHutchison, J. G. Current therapy for hepatitis C: pegylated interferon and ribavirin / J. G. McHutchison, M. W. Fried // Clin. Liver. Dis. -2003.-Vol. 7.-P. 149−161.
- Modulation of endothelial cell inflammatory integrins and stress markers with Rh-factor Vila in patients with advanced chronic hepatitis C /
- D. H. Van Thiel, A. Anantharaiu, A. L. Mindikoqlu et al. // J. Vir. Hep. -2003.-Vol. 10, № 4.-P. 310−317.
- Nitric oxide in patients with chronic liver diseases / A. E. Parvu et al. // Roman. J. Gastroenterol. 2005. — Vol. 14, № 3. — P. 225−230.
- Park, S. Biology and significance of T-cell apoptosis in the liver / S. Park, D. Murray, B. John, I. N. Crispe // Immunol. Cell Biol. 2002. — Vol. 80.-P. 74−83.
- Petri, B. Molecular events during leukocyte diapedesis / B. Petri, M. G. Bixel // FEBS J. 2006. — Vol. 273. — P. 4399−4407.
- Pinzani, M. Cytokine receptors and signaling in hepatic stellate cells / M. Pinzani, F. Marra // Semin. Liver. Dis. 2001. — Vol. 21, № 3. — P. 397 416.
- Pinzani, M. Fibrosis in chronic liver diseases: diagnosis and management / M. Pinzani, K. Rombouts, S. Colagrande // J. Hepatol. -2005.-Vol. 42.-P. 22−36.
- Pinzani, M. Liver fibrosis: from the bench to clinical targets / M. Pinzani, K. Rombouts // Dig. Liver. Dis. 2004. — Vol. 36, № 4. — P. 231 242.
- Pirfenidone effectively reverses experimental liver fibrosis / L. Garcia, I. Hernandez, A. Sandoval et al. // J. Hepatol. 2002. — Vol. 37, № 6. — P. 797−805.
- Plasma nitrate/nitrite and endothelin-1 in patients with liver cirrhosis / A. Curgunlu, P. Vural, M. Canbaz et al. // J. Clin. Lab. Anal. 2005. -Vol. 19, № 5. -P. 177−181.
- Plasma P-selectin levels are elevated in patients with chronic liver disease / F. Tacke, P. Schoffski, C. Trautwein et al. // Blood. Coagul. Fibrinol. 2003. — Vol. 14, № 4. — P. 319−325.
- Pockros, P. J. Noninvasive markers of fibrosis in chronic hepatitis patients / P. J. Pockros // J. Clin. Gastroenterol. 2006. — Vol. 40, № 6. — P. 461−463.
- Polzien, F. Increased intercellular adhesion molecule-1 serum concentration in cholestasis / F. Polzien, G. Ramadori // J. Hepatol. 1996. -Vol. 25, № 6.-P. 877−886.
- Prognostic value of quantitative liver function tests in viral cirrhosis: a prospective study / L. Addario, G. Scaglione, G. Tritto et al. // Eur. J. Gastroenterol. Hepatol. 2006. — Vol. 18, № 7. — P. 713−720.
- Rachwal, A. W. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis / A. W. Rachwal, D. R. Brigstock // Hepatol. Res. 2003. -Vol. 26, № l.-P. 1−9.
- Ramaiah, S. K. Role of neutrophils in the pathogenesis of acute inflammatory liver injury / S. K. Ramaiah, H. Jaeschke // Toxicol. Pathol. -2007.-Vol. 35.-P. 757−766.
- Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood / L. Spahr, L. Rubbia-Brandt, J. Pugin et al. // J. Hepatol. 2001. -Vol. 35, № 5. p. 582−589.
- Relevance of ICAM-1 to alcoholic liver cirrhosis / Y. Mandi, I. Nagy, L. Krenacs et al. // Pathobiology. 1996. — Vol. 64. — P. 46−52.
- Reversal effect of thalidomide on established hepatic cirrhosis in rats via inhibition of nuclear facroe-kappaB/inhibitor of nuclear factor-kappaB pathway / P. Lv, H. S. Luo, X. P. Zhou et al. // Arch. Med. Res. 2007. -Vol. 38, № l.-P. 15−27.
- Rockey, D. C. Antifibrotic therapy in chronic liver disease / D. C. Rockey // Clin. Gastroenterol. Hepatol. 2005. — Vol. 3, № 2. — P. 95−107.
- Role of LPS in the hepatic microvacsular dysfunction elicited by cecal ligation and puncture in mice / G. Singer, J. Houghton, C. A. Rivera et al. // J. Hepatol. 2007. — Vol. 47. — P. 799−806.
- Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection / A. Regev, M. Berho, L. Jeffers et al. // Am. J. Gastroenterol. -2002. Vol. 97. — P. 2614−2618.
- Sampling variability on percutaneous liver biopsy in patients with chronic hepatitis C viral infection /1. Siddique, H. A. El-Naga, J. P. Madda et al. // Scand. J. Gastroenterol. 2003. — Vol. 38. — P. 427−432.
- Schuppan, D. Hepatic fibrosis: from bench to bedside / D. Schuppan, Y. Porov // J. Gastroenterol. Hepatol. 2002. — Vol. 17, Suppl. 3. — P. 300 305.
- Schuppan, D. Hepatitis C and liver fibrosis / D. Schuppan, A. Krebs, M. Bauer, E. G. Hahn // Cell. Death. Differ. 2003. — Vol. 10. — P. 59−67.
- Senzolo, M. New insights into the coagulopathy of liver disease and liver transplantation / M. Senzolo, P. Burra, E. Cholongitas, A. K. Burroughs // World. J. Gastroenterol. 2006. — Vol. 12, №> 48. — P. 77 257 736.
- Serum concentration of adhesion molecules in postoperative biliary atresia patients: relationship to disease activity and cirrhosis / H. Kobayashi, K. Horikoshi, L. Long et al. // J. Pediatr. Surg. 2001. — Vol. 36, № 8. — P. 1297−1301.
- Serum intercellular adhesion molecule-1 and long-term response to IFN-a-2b therapy in chronic hepatitis C / M. Bagnasco, A. M. Riccio, M. Sinelli et al. // J. Interferon. Cytokine. Res. 1998. — Vol. 18. — P. 963 966.
- Serum intercellular adhesion molecule-1 concentration in interferon alpha treated patients with chronic viral C hepatitis / I. Warakomska, A. Wiczkowski, L. Kepa et al. // Wiad. Lek. 2004. — Vol. 57, № 11−12. — P. 641−646.
- Serum intercellular adhesion molecule-1 in alcoholic liver disease and its relationship with histological disease severity / A. S. Douds, A. Guan Lim, R. P. Jazrawi et al. // J. Hepatol. 1997. — Vol. 26, № 2. — P. 280 286.
- Serum intercellular adhesion molecule-1 in children with chronic liver disease: relationship to disease activity / A. Abdalla, A. A. Sheesha, M. Shokeir et al. // Dig. Dis. Sci. 2002. — Vol. 47, № 6. — P. 1206−1208.
- Serum intercellular adhesion molecule-1 in chronic hepatitis C: association with disease activity and response to interferon alpha / K. T. Nouri-Aria, J. Koskinas, C. J. Tibbs et al. // Gut. 1995. — Vol. 36, № 4. -P. 599−603.i 1 «' '
- Serum level of soluble vascular cell adhesion molecule 1 is a valuable prognostic marker in colorectal carcinoma / Y. Okugawa, C. Miki, Y. Toiyama et al. // Dis. Colon. Rectum. 2009. — Vol. 52, № 7. — P. 13 301 336.
- Serum levels of intercellular adhesion molecule-1 and nitric oxide in patients with chronic hepatitis related to hepatitis C virus: connection fibrosis / C. Pata, A. Yazar, E. Altintas et al. // Hepatogastroenterol. -2003. Vol. 50, № 51. — P. 794−797.
- Serum levels of soluble intercellular adhesion molecule-1 in chronic hepatitis B patients treated with interferon / R. D. Zheng, M. F. Zhang, R. C.
- Rao et al. // J. Southeast. China. National. Defence. Med. Sci. 2004. -Vol. 6, № 6.-P. 417−418.
- Serum levels of soluble vascular cell adhesion molecule are related to hyperdynamic circulation in patients with liver cirrhosis / O. Iacono, D. Rincon, A. Hernando et al. // Liver. Inter. 2008. — Vol. 28, № 8. — P. 1129−1135.
- Serum soluble adhesion molecules in chronic liver diseases / M. Sacaguchi, M. Zeniya, H. Takahashi et al. // Tokyo. Jikeikai. Med. J. -2004.-Vol. 119, № l.-P. 117−127.
- Serum soluble vascular-cell adhesion molecule-1 in patients with acute and chronic liver diseases / M. Pirisi, C. Fabris, E. Falleti et al. // Dis. Markers.-1996.-Vol. 13, № l.-P. 11−17.
- Shiffman, M. L. Triple therapy for genotype 1 infection: telaprevir or boceprevir / M. L. Shiffman, R. Esteban // Liver. Inter. 2012. — Vol. 32, Suppl. l.-P. 54−60.
- Shuji, I. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis / I. Shuji, Y. Toyokazu, U. Shinichiro, Y. Massayoshi // Alcohol. Clin. Exp. Res. -2007. Vol. 31, № 1. — P. S83−87.
- Signals mediating cleavage of intercellular adhesion molecule-1 / N. L. Tsakadze, U. Sen, Z. Zhao et al. // Am. J. Physiol. Cell. Physiol. 2004. -Vol. 287. — C.55−63.
- Soluble E-selectin and vascular cell adhesion molecule-1 in primary biliary cirrhosis / A. G. Lim, R. P. Jazrawi, J. H. Levy et al. // J. Hepatol. -1995. Vol. 22, № 4. — P. 416−422.
- Soluble ICAM-1 in patients with chronic hepatitis C infection: a prognostic marker of disease activity / A. M. El-Gohary, N. A. Fawas, H. M. Hassoba et al. // Egypt. J. Immunol. 2004. — Vol. 11. — P. 109−119.
- Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic cid and immunesupressive therapy / A. G. Lim, F. H. Wolfhagen, A. Verma et al. // Eur. J. Gastroenterol. Hepatol. 1997. -Vol. 9, № 2.-P. 155−161.
- Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis / A. G. Lim, R. P. Jazrawi, H. A. Ahmed et al. // Hepatology. 1994. — Vol. 20, № 1. -P. 882−888.1
- Soluble intercellular adhesion molecule-1 in sera from patients with chronic hepatitis C undergoing interferon treatment / A. M. Sonnante, R. Cozzolongo, R. Cuppone et al. // Arch. Virol. 1997. — Vol. 142, № 3. -P. 567−569.
- Soluble intercellular adhesion molecule-1 in sera of patients with chronic hepatitis C / M. El-Shazly, N. Yehia Aly, I. El-Shimi et al. // Bull. Alexandria Faculty Med. 2007. — Vol. 43, № 4. — P. 943−948.
- Soluble intercellular adhesion molecule-1 (s-ICAM-l/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome / M. J. Terol, M. Tormo, J. A. Martinez-Climent et al. // Annals. Oncol. 2003. — Vol. 14. — P. 467−474.
- Son, E.-W. Vitamin C blocks TNF-a-induced NF-kB activation and ICAM-1 expression in human neuroblastoma cells / E.-W. Son, S.-J. Mo,
- D.-K. Rhee, S. Pyo // Arch. Pharmacol. Research. 2004. — Vol. 27, № 10. -P. 1073−1079.
- Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C / G. Sebastiani, A. Vario, M. Guido et al. // J. Hepatol. 2006. — Vol. 44. — P. 686−693.
- Stolpe, A. Intercellular adhesion molecule-1 / A. Stolpe, P. T. Saag // J. Mol. Med.- 1996.-Vol. 74, № i.p. 13.33.
- Structural basis for dimerization of ICAM-1 on the cell surface / Y. Yang, C. D. Jun, J. H. Liu et al. // Mol. Cell. 2004. — Vol. 14. — P. 269 276.
- Suzuki, E. Nitric oxide involvement in depression during interferonalpha therapy / E. Suzuki, Y. Yoshida, A. Shibuya, H. Miyaoka // Int. J. Neuropsychopharacol. 2003. — Vol. 6. — P. 415−419.
- Telaprevir for previously untreated chronic hepatitis C virus infection / I. Jacobson, J. McHutchison, G. Dusheiko et al. // N. Engl. J. Med. -2011.-Vol. 364.-P. 2405−2416.
- Thalidomide in rat liver cirrhosis: blockade of tumor necrosis factor-alpha via inhibition of degradation of an inhibitor of nuclear factor-kappaB / S. C. Paul, P. Lv, Y. Xiao et al. // Pathobiology. 2006. — Vol. 73, № 2. -P. 82−92.
- Thalidomide prevents rat liver cirrhosis via inhibition of oxidative stress / P. Lv, H. S. Luo, X. P. Zhou et al. // Pathol. Res. Pract. 2006. -Vol. 202, № 11.-P. 777−788.
- The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure / W.-H. Yin, J.-W. Chen, H.-L. Jen et al. // Eur. J. Heart. Fail. 2003. — Vol. 5, № 4. — P. 507−516.
- The role of tumor necrosis factor-a in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride / P. P. Simeonova, R. M. Gallucci, T. Hulderman et al. // Toxicol. Appl. Pharmacol. 2001. — Vol. 177, № 2. -P. 112−120.
- TNF-alpha-induced endothelial cell adhesion molecule expression is cytochrome P-450 monooxygenase dependent / M. Sasaki, D. Ostanin, J. W. Elrod et al. // Am. J. Physiol. Cell. Physiol. — 2003. — Vol. 284, № 2. — P. C422-C428.
- TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1 relevance for concanavalin A-induced hepatitis / D. Wolf, R. Hallmann, G. Sass et al. // J. Immunol. — 2001. -Vol. 166, № 2.-P. 1300−1307.
- Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells / Y.-H. Paik, R. F. Schwabe, R. Bataller et al. // Hepatology. 2003. — Vol. 37, № 5. — P. 1043−1055.
- Transcellular diapedesis is initiated by invasive podosomes / C. V. Carman, P. T. Sage, T. E. Sciuto et al. // Immunity. 2007. — Vol. 26. — P. 784−797.
- Transient elastography: a new noninvasive method for assessment of hepatic fibrosis / L. Sandrin, B. Fourquet, J. Hasquenoph et al. // Ultrasound. Med. Biol.-2003.-Vol. 29.-P. 1705−1713.
- Turkay, C. Nitric oxide and renal functions in liver cirrhosis / C. Turkay, O. Yonem, O. Arikan, E. Baskin // Turk. J. Gastroenterol. 2004. -Vol. 15, № 2.-P. 73−76.
- Ultrastructural localization of integrin subunits alpha 3 and alpha 6 in capillarized sinusoids of the human cirrhotic liver / F. Quondamatteo, C. Kempkensteffen, N. Miosge et al. // Histol. Hepatol. 2004. — Vol. 19, № 3.-P. 799−806.
- Van Buul, J. D. Signaling in leukocyte transendothelial migration / J. D. van Buul, P. L. Hordijk //Arterioscler. Thromb. Vase. Biol. 2004. -Vol. 24.-P. 824−833.
- Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tracts / C. Garcia-Monzon, F. Sanchez-Madrid, L. Garcia-Buey et al. // Gastroenterology. 1995. — Vol. 108, № l.-P. 231−241.
- Vascular cell adhesion molecule-1 as a prognostic marker in patients with end-stage heart failure / M.-C. Chiang, W.-H. Yin, H.-L. Jen et al. // Acta. Cardiol. Sin. 2004. — Vol. 20. — P. 94−104.
- Vestweber, D. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium / D. Vestweber // Immunol. Rev. 2007. — Vol. 218. — P. 178−196.
- Volpes, R. Hepatic expression of intercellular adhesion molecule-1 in viral hepatitis B / R. Volpes, J. J. Van Den Oord, V. J. Desmet // Hepatology.- 1990.-Vol. 12.-P. 148−154.
- Walzog, B. Adhesion molecules: the path to a new understanding of acute inflammation / B. Walzog, P. Gaehtgens // News. Physiol. Sci. 2000. -Vol. 15,№ 3.p. 107−113.
- Weber, C. The role of junctional adhesion molecules in vascular inflammation / C. Weber, L. Fraemohs, E. Dejana / Nat. Rev. Immunol. -2007.-Vol. 7.-P. 467−477.
- Witkowska, A. M. Soluble ICAM-1: a marker of vascular inflammation and lifestyle / A. M. Witkowska // Cytokine. 2005. — Vol. 31, № 2.-P. 127−134.
- Witkowska, A. M. Soluble intercellular adhesion molecule-1: an overview / A. M. Witkowska, M. H. Borawska // Eur. Cytokine. Netw. -2004. Vol. 15, № 2. — P. 91−98.
- Yang, S.-S. Circulating soluble intercellular adhesion molecule-1 in type C viral hepatitis / S.-S. Yang, G. Tsai, C.-H. Wu, D.-S. Chen // Hepato-gastroenterol. 1996. — Vol. 43, № 9. — P. 575−581.
- Yao, H. P. Serum levels of sFas, sICAM-1, IL-18 in patients with chronic hepatitis C and their clinical significance. / H. P. Yao, D. J. Xia, L. H. Zhang, K. Z. Liu // Zhejiang. Da. Xue. Xue. Bao. Yi. Xue. Ban. 2002. -Vol. 31, № 1.-P. 2−5.
- Yu, I. Predicting prognosis among cirrhotic patients: Child-Pugh versus APACHE III versus MELD scoring systems / I. Yu, L. Abola // Phil. J. Gastroenterol. 2006. — Vol. 2. — P. 19−24.
- Yutaro, K. Effect of interferon treatment with chronic hepatitis C on serum level of thrombomodulin / K. Yutaro, H. Takeshi, K. Asahi, M. Shiro // Acta. Hepatologica. Japonica. 2002. — Vol. 43, № 1. — P. 18−27.
- Zaman, A. Risk factors ibr the presence of varices in cirrhotic patients without a history of variceal hemorrhage / A. Zaman, T. Becker, J. Lapidus, K. Benner//Arch. Intern. Med. 2001. — Vol. 161, № 21. — P. 2564−2570.
- Zheng, R. D. Advance in the relationship between the mutation of intercellular adhesion molecule and the chronicity and severity of hepatitis В / R. D. Zheng, C. R. Xu, X. Q. Zhang, Y. M. Wang // J. Clin. Hepatol. -2003. Vol. 6, № 4. — P. 254−255.